Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-09-14

Clinical Trial Update: Safety and Efficacy of an Ophthalmic Solution in Dry Eye Disease [Phase 2]

View source ↗

Summary

Phase 2 trial update assessing safety and efficacy of an ophthalmic solution for dry eye disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ophthalmic Solution

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Dry Eye Disease | Phase 2 | Status: COMPLETED | Results posted: 2020-09-14